Oxymatrine-loaded arabinoxylan hydrogel for robust targeting therapy of ulcerative colitis

Key Points

• Oxymatrine-loaded arabinoxylan hydrogel shows enhanced targeting therapy for ulcerative colitis.
• The targeted delivery demonstrated significant reduction in clinical symptoms of colitis.
• Assessment using drug delivery systems reveals the hydrogel's potential in treating gastrointestinal disorders.
• This work highlights a new avenue for targeted therapy, needing further clinical validation.